{"id":"W2996597631","doi":"10.1111/hiv.12835","title":"Response to Noe, Oldenbuettel and Jaeger","year":2019,"lang":"en","type":"letter","venue":"HIV Medicine","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Tenofovir alafenamide; Medicine; Emtricitabine; Weight gain; Dolutegravir; Weight change; Internal medicine; Weight loss; Clinical trial; Oncology; Human immunodeficiency virus (HIV); Body weight; Antiretroviral therapy; Family medicine; Obesity; Viral load","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005380478,0.0005840591,0.001192068,0.0006992107,0.00006593559,0.00001499946,0.0001504679,0.0005766137,0.00153097],"category_scores_gemma":[0.0003163951,0.0004020364,0.0000970564,0.0002983039,0.0001520057,0.00003848924,0.00008020746,0.001074638,0.00323962],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001955216,"about_ca_system_score_gemma":0.0002684735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000156434,"about_ca_topic_score_gemma":0.000002173775,"domain_scores_codex":[0.9971207,0.0001300568,0.000509391,0.0007791153,0.0008794331,0.0005812603],"domain_scores_gemma":[0.9980936,0.0005865952,0.0001245749,0.0007906815,0.0001278137,0.0002767422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007939062,0.0000332355,0.002296759,0.0002782454,0.0002501452,0.003613907,0.001203195,5.584164e-8,0.0004255271,0.0000039942,0.990319,0.0007820612],"study_design_scores_gemma":[0.004457756,0.0004360509,0.004831298,0.001789475,0.000528393,0.0003750774,0.00006790588,0.00000397539,0.00008590229,0.00001082047,0.9870417,0.000371702],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.009576997,0.0008330449,0.00004189045,0.9777433,0.0006661895,0.001242001,0.00003000247,0.0001132935,0.009753231],"genre_scores_gemma":[0.0004060707,0.0001111771,0.0005771615,0.5615624,0.002462127,0.00005902968,0.0004686716,0.00007960467,0.4342738],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.4245206,"threshold_uncertainty_score":0.9998432,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01619060627245068,"score_gpt":0.2679197899759195,"score_spread":0.2517291837034689,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}